A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
about
Regular treatment with formoterol for chronic asthma: serious adverse eventsLong-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroidLong-acting beta2-agonists for stable chronic asthmaLong-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthmaBeta-agonist intrinsic efficacy: measurement and clinical significance.Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma.Optimising treatment for COPD--new strategies for combination therapySafe use of long-acting β-agonists: what have we learnt?Pharmacotherapy for the treatment of asthma: current treatment options and future directions.Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial.Efficacy and safety of indacaterol, a new 24-hour beta2-agonist, in patients with asthma: a dose-ranging study.A respiratory therapist-directed protocol for managing inpatients with asthma and COPD incorporating a long-acting bronchodilator.Budesonide/formoterol maintenance and reliever therapy in asthma control: acute, dose-related effects and real-life effectiveness.Use and safety of long-acting β2-agonists for pediatric asthma
P2860
Q24200353-7EBAFC5A-C53F-4E96-8609-EB99824AA2A8Q24246441-B42CA5D4-5A50-4C8A-9864-0B55245E630DQ24247926-69C08D5B-456B-4B61-93F4-8E7B8F83890CQ24634033-42EED456-25C9-4C87-8A62-3612BBC44E66Q34642515-FCF2798C-473A-46F5-B0EE-C80859ED1BB0Q35627925-F44B5634-612A-449D-8B90-6107FCAF6C78Q37135100-9ABD43E9-BA94-4BCE-9630-F2F1AD4E90AAQ37336771-64378F02-1182-45F7-BCE6-F79FDC13BDF2Q37869146-ED0A7372-553A-44A1-9D3E-54A55A3CBBB6Q38579908-04B3E697-3513-48A6-A8EE-5E7BADEFEAB6Q43912252-F4DCDEB8-05A1-41EA-B4D4-9E694EDF15FDQ46196657-A6559053-78E8-4097-9A57-A4BE7B2BBDD4Q46413552-7AA4DA34-1EBE-4B28-9614-88FAF93C6EEBQ51686583-2A8BC349-B58B-4F7E-BA90-5A0465411DDDQ57821604-FE431985-9F32-43D0-BC61-59E5798DC5B0
P2860
A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A randomized, 12-week, double- ...... lbuterol metered-dose inhaler.
@ast
A randomized, 12-week, double- ...... lbuterol metered-dose inhaler.
@en
type
label
A randomized, 12-week, double- ...... lbuterol metered-dose inhaler.
@ast
A randomized, 12-week, double- ...... lbuterol metered-dose inhaler.
@en
prefLabel
A randomized, 12-week, double- ...... lbuterol metered-dose inhaler.
@ast
A randomized, 12-week, double- ...... lbuterol metered-dose inhaler.
@en
P2093
P1476
A randomized, 12-week, double- ...... lbuterol metered-dose inhaler.
@en
P2093
B E Levine
G Della Cioppa
R J Lapidus
P356
10.1016/S1081-1206(10)62351-4
P577
2001-01-01T00:00:00Z